Vardenafil + Dapoxetine

This product combines two active ingredients that address different aspects of male sexual dysfunction ^[1][4]. Vardenafil is a PDE5 inhibitor of the same class as sildenafil and tadalafil and is used to treat erectile dysfunction ^[4]. Dapoxetine is a selective serotonin reuptake inhibitor that, unlike the SSRIs taken for depression, is absorbed and cleared quickly, which makes it suitable for on-demand dosing shortly before intercourse rather than daily use ^[1]. The combination is intended for men who experience erectile dysfunction and premature ejaculation at the same time ^[2].

Dapoxetine was developed specifically for premature ejaculation and is approved for that indication in many countries, though it is not approved in the United States ^[1]. Pooled analyses of randomized trials show that on-demand dapoxetine lengthens the intravaginal ejaculatory latency time and reduces the personal distress associated with premature ejaculation, with an acceptable safety profile ^[1].

Because premature ejaculation and erectile dysfunction frequently occur together, clinicians have paired a PDE5 inhibitor with dapoxetine to treat both problems at once ^[2]. Studies of PDE5 inhibitors given together with dapoxetine have reported greater improvements in ejaculatory latency and patient satisfaction than either drug used alone in men with premature ejaculation ^[2]. Vardenafil itself has separately been shown to increase ejaculatory latency in men with lifelong premature ejaculation, supporting a complementary role alongside dapoxetine ^[3].

Fixed-dose tablets that combine vardenafil with dapoxetine are marketed in some regions, although regulatory approval varies by country and such combinations are not authorized everywhere ^[1][4]. Reported side effects reflect those of the two components: from dapoxetine, nausea, dizziness, headache and dry mouth; and from vardenafil, headache, facial flushing and nasal congestion ^[1][3]. As with vardenafil alone, the combination should not be used together with nitrate medications, and dapoxetine carries the usual cautions around SSRIs, including interactions with other serotonergic drugs ^[4].

This is a prescription combination. From the vardenafil side, expect headache, flushing, nasal congestion, and indigestion, and it must never be combined with nitrates or the pulmonary drug riociguat because the pair can cause a dangerous drop in blood pressure; caution also applies with alpha blockers and strong CYP3A4 inhibitors. Vardenafil can lengthen the QT interval, so it is avoided with class IA or class III antiarrhythmics, and rare priapism or sudden loss of vision or hearing needs urgent care. From the dapoxetine side, nausea, dizziness, headache, insomnia, and fainting or low blood pressure on standing can occur, and it should not be combined with MAO inhibitors, other serotonergic drugs (serotonin syndrome risk), or thioridazine. Men with significant heart disease or unstable blood pressure should be assessed before starting.

This product combines two separately developed drugs whose histories converge on male sexual health. Vardenafil is a phosphodiesterase type 5 inhibitor developed by Bayer and approved in 2003 as Levitra for erectile dysfunction. Dapoxetine is a short-acting selective serotonin reuptake inhibitor originally investigated by Eli Lilly; unlike the antidepressant SSRIs, it was deliberately engineered with rapid absorption and quick elimination so it could be taken on demand, and it became the first drug developed and approved specifically for premature ejaculation, gaining approval in a number of European and other countries under the name Priligy.

Recognizing that erectile dysfunction and premature ejaculation frequently occur together, manufacturers, particularly generic producers in India, combined the two agents into fixed-dose on-demand tablets marketed under names such as Super Vilitra. The pairing reflects a practical clinical rationale rather than a single original discovery program; each component retains the history and mechanism of its parent drug.

The vardenafil and dapoxetine combination is valued for addressing two common and often coexisting male sexual complaints in a single on-demand tablet, which many users find convenient. The logic behind it is sound and well supported; vardenafil reliably improves erections by enhancing the nitric-oxide and cyclic GMP pathway, while dapoxetine raises the ejaculatory threshold by increasing serotonin signaling, and expert reviews of male sexual dysfunction generally support using a PDE5 inhibitor together with dapoxetine when both conditions are present.

Dapoxetine's fast onset and short duration make it well suited to as-needed use, limiting the daily exposure associated with conventional SSRIs. It is worth noting that fixed-dose combinations of this type are not approved in every country and are often produced as generics, so quality and regulatory status vary by market. Where the two components are individually established, however, the combination represents a rational and appealing approach for men facing both problems at once.